Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1866220

Cover Image

PUBLISHER: SPER Market Research Pvt. Ltd. | PRODUCT CODE: 1866220

Global Biopharmaceuticals Manufacturing Consumables Testing Market Growth, Size, Trends Analysis - By Service, By Raw Material - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

PUBLISHED:
PAGES: 273 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Group License)
USD 5650
PDF (Company License)
USD 7450

Add to Cart

Global Biopharmaceuticals Manufacturing Consumables Testing Market Introduction and Overview

According to SPER market research, 'Global Biopharmaceuticals Manufacturing Consumables Testing Market Size- By Service, By Raw Material - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Biopharmaceuticals Manufacturing Consumables Testing Market is predicted to reach 2098.43 million by 2034 with a CAGR of 12.62%.

Biopharmaceutical manufacturing consumables testing involves assessing the quality and performance of materials utilized in the biopharmaceutical production process, such as bioreactors, filtration systems, and chromatography columns. With the rise in chronic diseases like cancer, autoimmune disorders, and neurological conditions, there is an increasing demand for biopharmaceuticals, mainly due to their enhanced efficacy and specificity in comparison to conventional medications.

Restraints: The complexity and expense associated with testing present considerable challenges for the Biopharmaceuticals Manufacturing Consumables Testing Market. As the biopharmaceutical sector evolves with more tailored and personalized treatments, the requirement for consumables like filters, bags, and tubing has intensified, resulting in increasingly sophisticated testing requirements. These consumables must comply with rigorous regulatory norms, including those imposed by the FDA and EMA, to assure product safety and effectiveness.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Service, By Raw Material

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Alcami Corporation, Merck KGaA, Eurofins Scientific, Agilent Technologies, Inc, Charles River Laboratories, Catalent, Inc, Element Materials Technology (Avomeen Analytical Services), Pace Analytical Services, LLC, Nelson Laboratories, LLC.

Global Biopharmaceuticals Manufacturing Consumables Testing Market Segmentation:

By Service: Based on the Service, Global Biopharmaceuticals Manufacturing Consumables Testing Market is segmented as; Laboratory Testing, Custom Testing / Customer Proprietary Testing, Compendial & Multi Compendial Laboratory Testing.

By Raw Material: Based on the Raw Material, Global Biopharmaceuticals Manufacturing Consumables Testing Market is segmented as; Formulation Excipients, Active Pharmaceutical Ingredients.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA25320

Table of Contents

1.Introduction

  • 1.1.Scope of the report
  • 1.2.Market segment analysis

2.Research Methodology

  • 2.1.Research data source
    • 2.1.1.Secondary Data
    • 2.1.2.Primary Data
    • 2.1.3.SPERs internal database
    • 2.1.4.Premium insight from KOLs
  • 2.2.Market size estimation
    • 2.2.1.Top-down and Bottom-up approach
  • 2.3.Data triangulation

3.Executive Summary

4.Market Dynamics

  • 4.1.Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1.Drivers
    • 4.1.2.Restraints
    • 4.1.3.Opportunities
    • 4.1.4.Challenges

5.Market variable and outlook

  • 5.1.SWOT Analysis
    • 5.1.1.Strengths
    • 5.1.2.Weaknesses
    • 5.1.3.Opportunities
    • 5.1.4.Threats
  • 5.2.PESTEL Analysis
    • 5.2.1.Political Landscape
    • 5.2.2.Economic Landscape
    • 5.2.3.Social Landscape
    • 5.2.4.Technological Landscape
    • 5.2.5.Environmental Landscape
    • 5.2.6.Legal Landscape
  • 5.3.PORTERs Five Forces
    • 5.3.1.Bargaining power of suppliers
    • 5.3.2.Bargaining power of buyers
    • 5.3.3.Threat of Substitute
    • 5.3.4.Threat of new entrant
    • 5.3.5.Competitive rivalry
  • 5.4.Heat Map Analysis

6.Competitive Landscape

  • 6.1.Global Biopharmaceuticals Manufacturing Consumables Testing Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Biopharmaceuticals Manufacturing Consumables Testing Market

7.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Service (USD Million) 2021-2034

  • 7.1.Laboratory Testing
  • 7.2.Custom Testing / Customer Proprietary Testing
  • 7.3.Compendial & Multi Compendial Laboratory Testing

8.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Raw Material (USD Million) 2021-2034

  • 8.1.Formulation Excipients
  • 8.2.Active Pharmaceutical Ingredients (API)

9.Global Biopharmaceuticals Manufacturing Consumables Testing Market, (USD Million) 2021-2034

  • 9.1.Global Biopharmaceuticals Manufacturing Consumables Testing Market Size and Market Share

10.Global Biopharmaceuticals Manufacturing Consumables Testing Market, By Region, (USD Million) 2021-2034

  • 10.1.Asia-Pacific
    • 10.1.1.Australia
    • 10.1.2.China
    • 10.1.3.India
    • 10.1.4.Japan
    • 10.1.5.South Korea
    • 10.1.6.Rest of Asia-Pacific
  • 10.2.Europe
    • 10.2.1.France
    • 10.2.2.Germany
    • 10.2.3.Italy
    • 10.2.4.Spain
    • 10.2.5.United Kingdom
    • 10.2.6.Rest of Europe
  • 10.3.Middle East and Africa
    • 10.3.1.Kingdom of Saudi Arabia
    • 10.3.2.United Arab Emirates
    • 10.3.3.Qatar
    • 10.3.4.South Africa
    • 10.3.5.Egypt
    • 10.3.6.Morocco
    • 10.3.7.Nigeria
    • 10.3.8.Rest of Middle-East and Africa
  • 10.4.North America
    • 10.4.1.Canada
    • 10.4.2.Mexico
    • 10.4.3.United States
  • 10.5.Latin America
    • 10.5.1.Argentina
    • 10.5.2.Brazil
    • 10.5.3.Rest of Latin America

11.Company Profile

  • 11.1.Alcami Corporation
    • 11.1.1.Company details
    • 11.1.2.Financial outlook
    • 11.1.3.Product summary
    • 11.1.4.Recent developments
  • 11.2.Merck KGaA
    • 11.2.1.Company details
    • 11.2.2.Financial outlook
    • 11.2.3.Product summary
    • 11.2.4.Recent developments
  • 11.3.Eurofins Scientific
    • 11.3.1.Company details
    • 11.3.2.Financial outlook
    • 11.3.3.Product summary
    • 11.3.4.Recent developments
  • 11.4.Agilent Technologies, Inc
    • 11.4.1.Company details
    • 11.4.2.Financial outlook
    • 11.4.3.Product summary
    • 11.4.4.Recent developments
  • 11.5.Charles River Laboratories
    • 11.5.1.Company details
    • 11.5.2.Financial outlook
    • 11.5.3.Product summary
    • 11.5.4.Recent developments
  • 11.6.Catalent, Inc
    • 11.6.1.Company details
    • 11.6.2.Financial outlook
    • 11.6.3.Product summary
    • 11.6.4.Recent developments
  • 11.7.Element Materials Technology (Avomeen Analytical Services)
    • 11.7.1.Company details
    • 11.7.2.Financial outlook
    • 11.7.3.Product summary
    • 11.7.4.Recent developments
  • 11.8.Pace Analytical Services, LLC
    • 11.8.1.Company details
    • 11.8.2.Financial outlook
    • 11.8.3.Product summary
    • 11.8.4.Recent developments
  • 11.9.Nelson Laboratories, LLC
    • 11.9.1.Company details
    • 11.9.2.Financial outlook
    • 11.9.3.Product summary
    • 11.9.4.Recent developments
  • 11.10.Others

12.Conclusion

13.List of Abbreviations

14.Reference Links

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!